Published in
Elsevier, Journal of Hepatology, 1(66), p. S609-S610
DOI: 10.1016/s0168-8278(17)31657-4
Links
Tools
CD103+ DCs are a key population in the progression of non-alcoholic steatohepatitis: could DCs represent a novel therapeutic application in NASH?
Journal article published in 2017 by
E.-C. Heier,
A. Meier 
,
T. Tschernig,
F. Lammert,
V. Lukacs-Kornek
,
T. Tschernig,
F. Lammert,
V. Lukacs-Kornek
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 